fixed-duration vs continuous therapy in cll
Published 2 years ago • 336 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
2:08
choosing between continuous versus fixed-duration therapy in cll
-
4:05
comparing continuous and fixed duration therapy in cll
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
1:34
time-limited vs continuous therapy in cll treatment
-
3:13
selection for time-limited & continuous therapy in cll
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
7:24
what are the current cll treatment options?
-
4:19
cll: what is 'watch & wait' and what can a patient do during this phase?
-
1:56
the future of fixed-duration therapy in cll
-
1:56
choosing between continuous and time-limited therapy in patients with high-risk cll
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
12:46
fixed duration treatment strategies in cll
-
1:32
cll14: feasibility of fixed-duration frontline therapy in cll
-
0:56
fixed-duration treatment strategies for frontline and relapsed cll
-
1:35
55-month follow-up from glow: fixed-duration ibr ven vs clb o in treatment naïve cll
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
2:43
outcomes in high-risk cll patients following fixed-duration treatment with ibrutinib plus venetoclax
-
3:22
current clinical practice for the diagnosis and treatment of cll
-
1:11
the prognostic value of ighv mutational status with continuous vs time-limited therapy in cll
-
1:22
shortening the duration of treatment with fixed-duration or mrd-adapted regimens in cll
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches